Contents: 100 x 0.5mg Tablets
Note: Strictly for research purposes only. Not for human consumption
Product Overview
Tesofensine is a powerful research compound that was initially investigated for neurodegenerative diseases and later found to exhibit significant appetite-suppressing and weight-modulating properties. It is categorized as a triple monoamine reuptake inhibitor and has demonstrated potential in preliminary trials for aiding fat loss mechanisms.
This listing is exclusively for researchers and laboratories. It is not meant for human use.
What’s Included
100 x 0.5mg tablets
Equivalent to a 100-day research supply
Premium-grade purity sourced from reliable synthesis providers
Secure and discreet packaging
Research Interest & Observed Benefits (in Laboratory Settings)
Appetite modulation via dopamine and serotonin regulation
Potential effects on fat metabolism and energy levels
May affect reward-driven eating behavior
Neurochemical stimulation without direct stimulant effects
Why This Is a Long-Term Value
Other suppliers generally provide only 30 tablets for £120 or more. Our 100-tablet research pack priced at £225 delivers unparalleled value and convenience for prolonged research:
100 days of data collection potential
Over 60% savings compared to short-term packs
Ideal for comprehensive metabolic or behavioral research
Important Notice
This product is strictly sold for laboratory research purposes. It is not intended for human consumption, therapeutic applications, or dietary supplementation.
Tesofensine + Retatrutide in Research Settings
When used together in a research context, Tesofensine may enhance the effects of GLP-1 and GIP receptor agonists such as Retatrutide by engaging alternative pathways:
Retatrutide: Hormonal appetite regulation & glucose control
Tesofensine: Central nervous system modulation & reward suppression
This multi-targeted approach is of interest in studies investigating long-term weight management, energy expenditure, and behavioral adherence in obese or insulin-resistant subjects.
